Location History:
- Ware, GB (1997 - 2005)
- Hertsfordshire, GB (2005 - 2009)
Company Filing History:
Years Active: 1997-2009
Title: An Overview of Rachel Ann Akehurst's Innovative Contributions
Introduction
Rachel Ann Akehurst, a prominent inventor based in Ware, GB, has made significant contributions in the field of pharmaceutical aerosol formulations. With a total of 21 patents to her name, her work primarily focuses on innovations aimed at improving the administration of medicaments via inhalation.
Latest Patents
Among Rachel's latest patents is a groundbreaking invention related to aerosol formulations useful for the administration of medicaments by inhalation. This innovative pharmaceutical aerosol formulation comprises particulate salbutamol along with physiologically acceptable salts and solvates, using fluorocarbon or hydrogen-containing chlorofluorocarbon as propellant. Notably, this formulation is designed to be substantially free of surfactants, enhancing its safety and efficacy.
Another significant patent involves an aerosol formulation containing particulate formoterol. This formulation includes a specific propellant consisting of 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoro-n-propane, combined with a polar cosolvent in a minor percentage. The composition achieves a particulate medicament concentration ranging from 0.005% to 5% w/w while ensuring surfactant levels remain extremely low.
Career Highlights
Rachel is an integral part of Glaxo Group Limited, where her research and innovations continue to drive advancements in respiratory medicine. Her academic background and extensive research experience equip her to explore novel solutions that address the needs of patients suffering from respiratory disorders.
Collaborations
Throughout her career, Rachel has worked alongside notable colleagues such as Anthony James Taylor and David Andrew Wyatt. This collaborative environment fosters innovation, enabling all team members to leverage their diverse expertise towards developing effective therapeutic solutions.
Conclusion
Rachel Ann Akehurst's contributions to the field of healthcare, particularly in the area of aerosol formulations, reflect her commitment to improving patient outcomes through innovative research. Her array of patents demonstrates both her expertise and her role in shaping the future of medications for respiratory disorders.